Windtree Therapeutics, Inc. (WINT)
0.0113
0.00 (0.00%)
USD |
OTCM |
Feb 13, 13:48
Windtree Therapeutics Cash from Investing (Quarterly) : -0.789M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agenus, Inc. | 0.076M |
| Curis, Inc. | 0.00 |
| LadRx Corp. | 0.00 |
| Plus Therapeutics, Inc. | 1.297M |
| Enzon Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.372M |
| Cash from Financing (Quarterly) | 7.063M |
| Free Cash Flow | -15.12M |
| Free Cash Flow Per Share (Quarterly) | -0.2389 |
| Free Cash Flow to Equity (Quarterly) | -10.61M |
| Free Cash Flow to Firm (Quarterly) | -6.080M |
| Free Cash Flow Yield | -16.27K% |